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Aims A significant proportion of left ventricle assist device (LVAD) patients have very difficult transthoracic echocardio-
graphic images. The aim of this study was to find an echocardiographic window which would provide better visual-




Based on the anatomic relationships in LVAD patients, a right intercostal transhepatic approach was proposed. By
using a computer simulator, we searched for the appropriate probe orientation. Further, 15 ambulatory LVAD
patients (age 56 ± 15 years, 73% males) underwent two echocardiographic studies: one normal transthoracic echo-
cardiography following the institutional protocol (Echo 1) and a second study which included the transhepatic ap-
proach (Echo 2). The two exams were performed by two different sonographers and the results validated by a
third observer for agreement. The transhepatic intercostal window was feasible in all patients, with an image quality
allowing good visualization of structures in 93%. Precise quantification of the left ventricular (LV) and right ven-
tricular (RV) function was achieved more often in the Echo 2 (10 vs. 3 patients for LV, P= 0.03 and 14 vs. 8
patients for RV, P= 0.04). A significant difference existed also in the quantification of the LVAD inflow cannula flow
by pulsed Doppler (11 patients in Echo 2 vs. 3 patients in Echo 1, P= 0.009).
...................................................................................................................................................................................................
Conclusion This is the first study describing a new echocardiographic window in LVAD patients. The transhepatic window may
provide better quantification of left and RV dimensions and function and improvement in Doppler interrogation of
the inflow cannula.
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Introduction
Left ventricular assist devices (LVAD) are increasingly used in the
treatment of end-stage heart failure.1 It can be used as a bridge to
other treatment options (bridge-to-decision, heart transplantation,
or even recovery) or as destination therapy.2–4 Current guidelines
recommend the routine use of echocardiography in the assessment
and follow-up of LVAD patients.5,6 However, a significant proportion
of these patients have very difficult transthoracic echocardiographic
images, because of the interposition of implanted materials and the
extensive post-operative changes in the intrathoracic anatomy.7
A possible approach to improving the quality of the image is enhance
visualization with the use of left ventricular (LV) contrast agents.8
Unfortunately, LV contrast agents cannot improve the visualization
of the heart when the ultrasound is blocked by hard implanted
material.
In this study, we describe our clinical experience with the transhe-
patic echocardiographic approach in consecutive LVAD patients,
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aiming to overcome difficult imaging due to the interposition of
implanted materials (LVAD pump, inflow cannula, and outflow graft)
between the probe and the heart. The hypothesis is that this new
echocardiographic window may provide complementary information
in cases where usual ultrasound imaging is severely limited.
Methods
As noted above, echocardiographic windows may be severely limited in
LVAD patients. Therefore, in our imaging group, a lot of effort was
directed towards improving the echocardiographic imaging in these
patients.8 Based on a study of the anatomical relationships between the
heart, its surrounding organs, and the LVAD system, derived from multi-
plane computed tomography images of LVAD patients, we proposed a
right intercostal transhepatic approach. This view was chosen by investi-
gating the possible echocardiographic windows that allowed interroga-
tion of the heart while avoiding the implanted material (LVAD pump and
drivelines, see Figure 1). We then used computer simulations as a theoret-
ical guide in order to reach an optimal probe position and orientation
that would allow to reproduce modified classical echocardiographic
views (Figures 1 and 2, Supplementary data online, Movies S1 and S2).
Computer simulations were performed by using the Heartworks simula-
tion software (HeartWorks Simulator v2.0.60.0 by Intelligent Ultrasound,
Cardiff, UK). In patients, the right intercostal transhepatic window was
obtained by first finding the subcostal four-chamber view, and then sliding
along the first adjacent intercostal space to the right, while maintaining
the probe rotation and the four-chamber image (Figures 1 and 2,
Supplementary data online, Movie S1). The aim was to obtain a four-
chamber view, avoiding the hard reflectors, usually located between the
heart and the thorax wall. For optimal alignment with the heart axis, it
may be necessary to go one intercostal space higher, in order to obtain
an ‘inverted four-chamber view’ (Supplementary data online, Movie S1).
The right ventricular (RV) view was obtained by 30–60 clockwise rota-
tion and anterior tilting of the probe (Figure 2, Supplementary data online,
Movies S2 and S4).
This approach has been used exclusively for the LVAD patients having
extremely poor or no transthoracic windows.
Study population
We prospectively included all consecutive LVAD patients, alive in 2018–
19, in whom a transhepatic window was included as part of the local
echocardiography protocol, because of the difficulty in appropriately
imaging these patients.
Since March 2016, in our tertiary referral centre, only HeartMate 3
LVAD is implanted as bridge-to-transplant or destination therapy, before
this date only HeartMate 2 were used. This pilot study was approved by
the institutional Medical Ethics Committee and conducted according to
Figure 1 The right intercostal transhepatic imaging plane, demonstrated on the simulator (HeartWorks v2.0.60.0, Inventive Medical Ltd,
MedaPhor Group plc 2019, UK) and on computed tomography on one LVAD patient. (A–C) Computer simulated direction of the probe and imaging
plane in order to obtain a four-chamber view: (A) frontal plane; (B) right lateral view; (C) inferior view; (D) the computer simulated echocardiography
demonstrating a modified four-chamber view, the liver is also in the imaging plane; (E) computed tomography angiogram (CTA) of an LVAD patient,
the transhepatic echocardiography imaging plane is drawn over the image as a transparent triangle in the frontal (A, anterior) plane; and (F) side view
of CTA images demonstrating the interposition of the outflow line between the heart and the chest wall. The echocardiography imaging plane, drawn
over the image as a line, is situated posterior to the outflow LVAD line, and intersects only the heart cavities; (G) inferior view of the same patient,
the transhepatic echocardiography imaging plane is drawn over the image as a transparent triangle. The LVAD is situated in the far field; and (H) 3D
reconstruction from CTA images of the same LVAD patient, in the frontal (A, anterior) plane. Bone structures have been excluded, in order to allow
visualization of the outflow line, situated between the heart and the chest wall. The echocardiography imaging plane, drawn over the image as a trans-
parent triangle, is situated posterior to the outflow LVAD line. LA, left atrium; LV, left ventricle; LVAD, Left ventricle assist device; RA, right atrium;
RV, right ventricle.

















































the principles of the Declaration of Helsinki. Written informed consent
was obtained from every participant.
Inclusion criteria:
• age >17 years,
• stable clinical status, and
• impossibility to obtain an echocardiographic apical view or very poor
quality of transthoracic imaging.
Exclusion criteria:
• restricted access to the classical echocardiographic windows due to in-
complete healing, complications, or pain and
• clinical instability.
Echocardiography
Two echocardiographic studies were performed, using a Philips EPIQ 7C
ultrasound system (Philips Medical Systems, Bothell, WA, USA),
equipped with an X5-1 transducer. At the first visit, each subject was
imaged by one of the two sonographers in the study (M.S.—highly experi-
enced imaging cardiologist specialized in LVAD echocardiography and
D.B.—highly experienced sonographer specialized in LVAD echocardiog-
raphy). At the second visit, the subjects were imaged by the second
sonographer. The time interval between the two exams was variable,
coupled to the outpatient clinic follow-up visits.
D.B. performed a complete echocardiographic examination (noted
with Echo 1 but not necessarily the first in order), following an extensive
internal protocol, based on the American Society of Echocardiography
recommendations.6 In short, this protocol investigates the heart in the
following echocardiographic windows:
• parasternal (LV long and short axis, modified long axis for the visualiza-
tion of the ascending aorta, RV long axis),
• apical (LV focused, with all classical views; RV focused with multiplane
and rotational imaging9),
• subcostal long and short axis, and
• suprasternal and right parasternal for visualization of the outflow
cannula.
M.S. performed a second study protocol (noted Echo 2) based on the
same views as D.B., to which was added a right intercostal transhepatic
approach, focused on the LV and RV.
In both studies (Echo 1 and Echo 2) the feasibility of each window was
noted, as well as the structures visualized. The quality of the image in trans-
hepatic view was assessed using a 4-grade scale (1: good, clear visualization
of all structures; 2: acceptable, structures can be visualized but there is ex-
cessive noise and/or some elements are not clearly defined; 3: bad, some
structures are not visible; and 4: null). If a certain parameter could be
obtained in multiple views (e.g. the RV function could be estimated in the
apical or subcostal windows, or the outflow cannula could be imaged in
parasternal or suprasternal position), only the view allowing most optimal
quantification and alignment with the structures was retained.
The two examinations (Echo 1 and 2) were performed in a reciprocal-
ly blinded manner by the two sonographers in the study. Each study result
was initially evaluated by the performing sonographer (D.B. and M.S., re-
spectively), and validated for agreement by K.C. and M.G. (highly experi-
enced cardiologists).
Figure 2 The transhepatic four-chamber view (A–D) and right ventricular view (E–H). (A and B) imaging plane and probe position demonstrated
on the simulator; (C) virtual transhepatic echocardiography, four-chamber view; (D) real transhepatic echocardiography, the same incidence on a
LVAD patient; (E and F) clockwise rotation of the probe and anterior tilting to obtain the right ventricular view; (G) virtual transhepatic echocardiog-
raphy, right ventricular view; and (H) real transhepatic echocardiography, the right ventricular view on an LVAD patient.










































































Continuous variables were represented as mean ± standard deviation.
Categorical data are presented as absolute number and percentages. For
comparison of normally distributed continuous variables, we used the de-
pendent or independent means t-test when appropriate. For comparison
of proportions, the v2 test or the Fisher’s exact test was used.
Every statistical analysis was performed using the Statistical Package for
Social Sciences version 25 (IBM SPSS Statistics for Windows, Armonk,
NY, USA). Testing was done two-sided and considered significant if the
P-value was smaller than 0.05.
Results
During 2018–19, 43 different LVAD patients were investigated by
echocardiography in the outpatient clinic and 15 were included in
this pilot study. Their general characteristics are presented in Table 1.
Male gender was predominant 73%, with an average age of
56± 15 years. Fourteen subjects had a HeartMate 3 device, and one
HeartMate 2. Most of the subjects (80%) had intracavitary leads,
mostly implantable cardiac-defibrillators (ICDs). Other thoracic sur-
gical procedures (valvular, coronary bypass, and re-LVAD) were also
present in this group (Table 1). They were not presented in a cumula-
tive manner since more instances were present simultaneously in
some subjects.
There was no significant difference in the feasibility per echocar-
diographic window between the two exams (Table 2), except of
course for the transhepatic window, which was specific to Echo 2.
The transhepatic window was obtained in all study subjects (Table 2),
with an image quality of 1(good) in eight (53%) patients, two (accept-
able) in six (40%) subjects, and three (bad) in one patient (7%). The
imaging depth was 26± 4 cm.
Both exams allowed qualitative evaluation of the left and RV func-
tion in similar percentages (Table 3). The outflow cannula flow was
also similarly imaged. Quantification of LV (ejection fraction by
Simpson method) and RV function (tricuspid annular plane systolic
excursion) was achieved more often in the Echo 2 (10 vs. 3 patients
for LV, P= 0.03 and 14 vs. 8 patients for RV, P= 0.04). Figure 3 dem-
onstrates the RV function assessment in transhepatic view. A signifi-
cant difference existed also in the quantification of the LVAD inflow
cannula (Figure 4) flow by pulsed Doppler (11 patients in Echo 2 vs. 3
patients in Echo 1, P= 0.009).
Discussion
In this study, we found that in LVAD patients with very poor trad-
itional echocardiographic windows: (i) the novel transhepatic inter-
costal approach for echocardiographic imaging is feasible; (ii)
resulting in a higher rate of LVAD patients to have a precise quantifi-
cation of LV and RV function; and (iii) a higher proportion of patients
to benefit from Doppler evaluation of LVAD inflow cannula.
LVADs are increasingly being used in the treatment of advanced
heart failure, as destination therapy, bridge-to-decision, or as bridge
to transplantation.1 Recovery is also a possible scenario in very lim-
ited, selected cases when the LVAD may even be explanted.10
Essential to these decisions, as well as for the follow-up of these
patients, is being able to reliably assess the function of the heart
chamber and the function of the LVAD pump. Currently, transthora-
cic echocardiography is the main imaging method used in the follow-
up of LVAD patients,5,6 due to its low cost, portability, repeatability,
and lack of adverse events. However, in most of the LVAD patients,
echocardiographic imaging is severely limited by the implanted ma-
terial (LVAD, drivelines, and connections), and this limitation is pos-
sibly under-reported.7,8
Given the strengths and limitations mentioned above, we aimed to
find an echocardiographic window, which would avoid the interpos-
ition of implanted material between the heart and the probe.
Because of the anatomic relationships between the heart, lungs, the
LVAD device, and its connections, a transhepatic approach is practic-
ally the only imaging plane corresponding to these conditions (see
Figure 1E–H). By using a computer simulator study, we were able to
search for a probe position, rotation, and angulation needed in order
to image the heart cavities from that position. This was followed by
in vivo testing, where the window proved to be highly feasible (100%
in our group) with acceptable or good image quality (according to
.................................................................................................
Table 1 General characteristics of the study group
(N5 15)
Characteristics Data
Age (years) 56 ± 15
Male gender 11 (73%)
Height (cm) 177 ± 10
Weight (kg) 85 ± 18
BMI (kg/m2) 27 ± 4
Systolic blood pressure at inclusion (mmHg) 106 ± 12
Diastolic blood pressure at inclusion (mmHg) 74 ± 7
Ischaemic cardiomyopathy 5 (33%)
CABG 1 (7%)
Re-LVAD 1 (7%)
Valve procedure (any position, surgical or percutaneous) 5 (33%)
Other implantable devices (PM and ICD) 12 (80%)
Time interval since LVAD implantation (years) 1.7 ± 0.9
Time interval between Echo 1 and Echo 2 (months) 3.3 ± 1.6
BMI, body mass index; CABG, coronary artery bypass graft; ICD, implantable car-
diac-defibrillator; LVAD, left ventricle assist device; PM, pacemaker.
.................................................................................................
Table 2 Feasibility data in the study group (N5 15)
Echocardiographic window Echo 1 Echo 2 P
Parasternal 14 (93%) 14 (93%) —
Apical LV 4 (27%) 4 (27%) —
Apical RV 8 (53%) 9 (60%) 1
Subcostal 11 (73%) 11 (73%) —
Suprasternal/right parasternal 12 (80%) 14 (93%) 0.6
Transhepatic 0 15 —
Transhepatic imaging depth (cm) — 26 ± 4 —
Transhepatic imaging frame rate (Hz) — 48 ± 10 —


































our definition, which takes into account the imaging depth and the
transhepatic passage) in 93%. However, the only LV view investigated
in the transhepatic window was the four-chamber view. This is be-
cause the manual probe rotation for a ventricle situated in the far field
and slightly angulated did not result in obtaining full-length two-cham-
ber or three-chamber view. The same problems were encountered
when using simultaneous multiplane or digital rotation of the imaging
plane, where the quality of the rotated image is also known to be
decreased.11
The transhepatic window allows for longitudinal views of the LV
and RV, but the heart is situated very deep, leading to a significant
drop in resolution and frame rates achievable (Figures 2 and 3,
Table 2). The quality of the image obtained was considered accept-
able in this particular group of patients having very limited access in
the classical windows (Table 2), because it was sufficient to allow visu-
alization of the cardiac structures and the assessment of function and
flow (Figures 3 and 4), with higher success rate than by classical ap-
proach (Table 3). The ultrasound, as shown in Figures 1 and 2, must
first traverse the hepatic parenchyma, which leads to loss of energy
through attenuation.12 In our study group, with an average body mass
index of 27 ± 4 and a long-standing history of heart failure, the inci-
dence of a fatty liver was of course lower, but variable degrees of liver
fibrosis remain possible.13 On the contrary, liver oedema may favour
the penetration of ultrasound. Transhepatic imaging has already been
proposed as a good alternative for vena cava inferior assessment dur-
ing heart surgery.14
The possible presence of large implanted material in the right heart
(valve replacement, tricuspid valvuloplasty, and right heart mechanic-
al circulatory support) may significantly reduce the feasibility of this
method. Defibrillator leads, although very frequent in our study
group, did not seem to modify the results. In this study, we demon-
strate that the transhepatic imaging plane has the potential to offer an
Figure 3 Right ventricular function assessed in transhepatic view by tricuspid annular plane systolic excursion (TAPSE). (A) general transhepatic
view of an ‘inverted’ four-chamber view. The TAPSE M-mode line is drawn over the image (dotted line). (B) TAPSE measurement from the transhe-
patic view. The systolic excursion is also inverted (downward movement in systole).
.................................................. .........................................................................
....................................................................................................................................................................................................................





P View where the parameter
was acquired Echo 1
View where the parameter














LV function qualitative 14 (93%) 15 (100%) 1 10 (67%) 4 (27%) 0 0 1 (7%) 4 (27%) 0 0 10 (67%)
LVEF Simpson (monoplan) 3 (20%) 10 (67%) 0.03 0 3 (20%) 0 0 0 4 (27%) 0 0 6 (40%)
RV function qualitative 12 (80%) 15 (100%) 0.2 1 (7%) 8 (53%) 3 (20%) 0 0 9 (60%) 0 0 6 (40%)
TAPSE 8 (53%) 14 (93%) 0.04 0 8 (53%) 0 0 0 9 (60%) 0 0 5 (33%)
Inflow cannula flow 3 (20%) 11 (73%) 0.009 0 2 (13%) 1 (7%) 0 1 (7%) 1 (7%) 0 0 9 (60%)
Outflow cannula flow 12 (80%) 15 (100%) 0.2 2 (13%) 0 0 10 (67%) 1 (7%) 0 0 14 (93%) 0
Significant P-values (<0.05) were highlighted in bold. LV, left ventricle; LVEF, left ventricular ejection fraction; TAPSE, tricuspid annular plane excursion.





























































acceptable visualization of the heart in cases where the standard
transthoracic windows are unusable. This is proven by the significant-
ly higher number of patients where precise quantification of LV and
RV function was possible by using a transhepatic window. This may
prove crucial in cases where therapeutic decisions rely on precise de-
termination of the heart dimensions or function (i.e. new onset of
symptoms, unexplained alarms, possible LV recovery). It may also re-
duce the need for more expensive, more invasive, or higher risk
investigations4–7 (computed tomography, angiography, and even
transoesophageal echocardiography). In this study, none of the sub-
jects benefited from the adjunction of LV contrast, which may en-
hance visualization of the heart chamber.15 Our research group has
demonstrated an added value of contrast imaging in LVAD patients.8
However, high imaging depth and the interposition of contrast-filled
structures (here the liver, atria, and/or the RV) may reduce the bene-
fit of contrast for LV visualization. This may be subject for future
research.
Furthermore, the very elusive inflow cannula7 could also be inter-
rogated in 73% of subjects as opposed to 20% by traditional echocar-
diography (P= 0.009). These numbers are relatively low in
comparison with old data reported on HeartMate 2 devices, which
are more than 80% in the global LVAD population.16,17 There are no
available reports on the real-life feasibility of the transthoracic
Doppler interrogation of the inflow cannula in HeartMate 3 patients.
Experts agree, however, that in new-generation LVADs the inflow
cannula may be more difficult to image due to specific Doppler arte-
facts.6,18 On the contrary, the observed feasibility for the outflow
cannula was excellent and similar for both echocardiographic studies
(Table 3). Also, our study population consisted of particularly difficult
patients, as reflected by the very low feasibility of the apical window
(27%, see Table 2). Being able to interrogate, both the inflow and out-
flow cannulas with regular transthoracic echocardiography is a not-
able advantage in these patients. Most of the adaptive changes in the
LVAD function, as well as a significant proportion of the alarms, are
related to changes in flow and can be understood by using a combin-
ation of imaging and LVAD flow readings.1,5,6
Limitations and future perspective
This is a small pilot study describing a novel approach to echocardio-
graphic imaging in challenging LVAD patients, with retrospective data
analysis, enrolling only a limited number of patients. This new window
may provide essential information for patient management when the
classical echocardiographic views are non-diagnostic. Studies in larger
population groups may further demonstrate the added value of the
transhepatic echocardiographic approach and the practical benefit
for LVAD patients on long-term follow-up.
In this monocentric study, the echocardiograms were performed
by two highly skilled imaging experts, specialized in LVAD imaging. It
is possible that the real-life feasibility of both the traditional ultra-
sound protocol and the new transhepatic window be lower, especial-
ly in particularly challenging cases. The transhepatic window is now
systematically used in all our LVAD patients for their follow-up
examinations. Based on this experience, we noticed that the learning
curve for this new window was around 20 first-hand echocardiog-
raphy examinations for a sonographer already familiar with the path-
ology. Obtaining the transhepatic images requires around five
additional minutes to the standard LVAD examination protocol.
Most of our patients had HeartMate 3 devices (only one
HeartMate 2). It is not sure whether the current results may be
extrapolated to other type of LVAD systems. However all main-
stream long-term LVAD types (HeartMate 2, HeartMate 3, and
HeartWare) closely resemble the HeartMate 3 with respect to their
implantation in the thorax; therefore, we expect similar benefits of
the transhepatic approach. The method should be tested in future
studies in patients implanted with all long-term LVAD models.
Figure 4 Colour Doppler and pulsed-wave Doppler interrogation of the LVAD inflow cannula. (A) The inflow cannula is situated in the far field, in
the LV apex. (B) By using pulsed-wave Doppler, we can measure the inflow velocities.





























































This is the first study describing a novel echocardiographic window
for appropriate cardiac imaging of LVAD patients with limited acous-
tic access. The transhepatic window provided better quantification of
LV and RV function and higher success rate for Doppler interrogation
of the inflow cannula in patients with LVAD and difficult transthoracic
echocardiographic image.
Supplementary material
Supplementary data are available at European Heart Journal -
Cardiovascular Imaging online.
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